Docor International Management

Venture Capital Active Tel Aviv-Yafo, Israel Est. 1995
Last updated 2026-06-18
Portfolio
27
in our dataset
Rounds participated
41
Rounds led
1
Rounds' value
$170.7M
total disclosed, rounds participated
Stages
B Round, F Round, E Round, G Round, C Round, Seed, A Round, D Round

About

Docor International Management's vision is to be a socially responsible investor with two main objectives: to contribute to the welfare of the Israeli economy and society by investing in companies that have activities in Israel or are based on technology developed in Israel, and to create worldwide added value by investing in globally oriented companies that have innovative technologies targeted at growing markets and the needs of future industries. Docor's strategy is to become actively involved in the management of the companies in which it invests. When investing in young companies with post-seed technology that is nearly proven, Docor provides an international business network and leverages investments. And while stayinginvolved with companies through their initial stages of growth, Docor offersskilled management support and models professional business conduct. Docor International Management is a fully owned subsidiary of Crecor BV. Both Docor and Crecor were formed as wholly owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Portfolio · 27

Bonfix
Minimally Invasive Hallux Valgus Correction
1 round Latest: 2023-03
OCON Therapeutics
Spherical Intrauterine Drug Delivery Platform
Led ★ 5 rounds $11.5M committed Latest: 2020-12
Raziel Therapeutics
Injectable Drug for Treatment of Obesity
2 rounds $26.5M committed Latest: 2019-12
Omnix Medical
Novel Antibiotic Agents to Combat Resistant Bacteria
1 round $3.5M committed Latest: 2018-12
Eximore
Ophthalmic Drug Delivery
1 round $3.0M committed Latest: 2018-05
SP Nano
Nanotechnology-enhanced Composite Materials
4 rounds $9.0M committed Latest: 2017-10
Colospan
Technology for Colorectal Surgery
1 round $7.7M committed Latest: 2017-09
Neragon Networks
Compact Wireless Communication Devices
1 round $600K committed Latest: 2017-01
Icebow
Custom Ice Cube Production Technology for Branding and Events
1 round $560K committed Latest: 2016-09
Xsight Systems
Data-based Runway Safety Solutions
1 round Latest: 2016-06
TPCera
Immunomodulatory Treatment for Autoimmune Diseases
1 round $750K committed Latest: 2016-05
EyeYon Medical
Ophthalmic Products for Vision-threatening Conditions
1 round $2.6M committed Latest: 2015-04
Check-Cap
Capsule-based Screening Technology for Detecting Colorectal Cancer
1 round $12.0M committed Latest: 2014-10
Similarweb
Web Analytics and Competitive Intelligence
2 rounds $4.6M committed Latest: 2013-09
EarlySense
Contact-free Continuous Monitoring Solutions
2 rounds $28.0M committed Latest: 2012-11
CollPlant
Products and Technologies for Regenerative and Aesthetic Medicine
3 rounds $13.8M committed Latest: 2012-02
Laryngoport
Flexible Endoscopic Platform for Laryngeal Microsurgery
1 round $1.0M committed Latest: 2012-01
MacroCure
Therapeutic Platform for Hard-to-Heal Wounds
1 round $13.0M committed Latest: 2011-04
Interna Therapeutics
Drug Delivery via Electrical Nano Motors
1 round $7.3M committed Latest: 2008-08
IceCure Medical
The choice of cryoablation for the minimally invasive destruction of benign and cancerous tumors
1 round $4.5M committed Latest: 2008-07
Fourier Education
Science Education Technology Solutions
2 rounds $4.5M committed Latest: 2008-03
Quiksee
Online Tour Technology
2 rounds $3.5M committed Latest: 2007-05
Protalix BioTherapeutics
Plant-based Proteins with Improved Therapeutic Profiles
1 round $5.3M committed Latest: 2005-12
Sirica
Infrared Detection and Imaging for Mass Markets
1 round Latest: 2005-04
Cellaris
Ultra-light Ceramic Foams
1 round $2.4M committed Latest: 2004-05
Humaneyes Technologies
Virtual Reality and Computer Vision
1 round $5.0M committed Latest: 2002-08
Inhavo
Real-time Personalization Engine
1 round

Investment activity

7 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences15
Industrial Technologies3
Business Software3
Aerospace, Defense & HLS2
Media & Entertainment Technologies1
Education & Knowledge Technologies1
Undisclosed1
Agriculture & Food Technologies1

Q&A

What is Docor International Management's investment thesis?
Docor International Management aims to be a socially responsible investor, contributing to the Israeli economy and society by investing in companies with Israeli activities or technology. They focus on globally oriented companies with innovative technologies for growing markets and future industries.
What is Docor International Management's strategy regarding portfolio companies?
Docor International Management's strategy involves active involvement in the management of its portfolio companies. For young, post-seed companies, they provide an international business network and leverage investments, offering skilled management support and professional business conduct through initial growth stages.
Which sectors does Docor International Management primarily invest in?
Docor International Management shows a strong concentration in Health Tech & Life Sciences, with 23 investment rounds and 15 portfolio companies in this sector. Other notable sectors include Industrial Technologies and Business Software.
What was a significant exit for Docor International Management in recent years?
In May 2021, Docor International Management saw an exit with Similarweb, which went public on the NYSE with a valuation of $1.65 billion.
Can you name another notable exit for Docor International Management?
Docor International Management also had an exit in March 2015 with Check-Cap, which went public on NASDAQ with a valuation of $92 million.
Which company did Docor International Management exit via acquisition?
In November 2014, Docor International Management exited Cellaris through an acquisition by Carborundum Universal Limited (CUMI).
What is the most recent investment round recorded for Docor International Management?
The most recent investment round recorded for Docor International Management was in March 2023.
Who are the key executives at Docor International Management?
The key executives at Docor International Management include Boaz Laor, CEO, and Adi Goldin and Tsachy (Isaac) Shasha, both Vice Presidents.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitedocor.com

Identifiers & details

Founded1995

Radar intelligence

Web history (Wayback)

Domaindocor.com

Certificate / subdomain footprint

Subdomains3